Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;16(2):268-273.
doi: 10.26574/maedica.2020.16.2.268.

Patients with Sticky Platelet Syndrome, Sickle Cell Disease and Glanzmann Syndrome May Promulgate Severe Thrombosis if Infected with Covid-19

Nitin Ashok John  1 , Jyoti John  2 , Praful Kamblec  1 , Anish Singhal  1 , Vandana Daulatabad  3 , I S Vamshidhar  1
Affiliations
Editorial

Patients with Sticky Platelet Syndrome, Sickle Cell Disease and Glanzmann Syndrome May Promulgate Severe Thrombosis if Infected with Covid-19

Nitin Ashok John et al. Maedica (Bucur). 2021 Jun.

Abstract

Covid-19 pandemic has been a very serious cause of health concern worldwide. Thrombosis has been a critical manifestation in severe Covid-19 infection. The increased arterial and venous thrombosis in patients with Covid-19 is proving to be life threatening. Sticky platelet syndrome and sickle cell disease are genetic disorders with procoagulant nature of the disease, while in Glanzmann syndrome there is an enhanced bleeding tendency, with pathological defect leading to altered platelet aggregation and delayed clot formation. Considering the thrombotic episodes of Covid-19, we decided to review the literature on data bases such as PubMed and Medline for knowing the coagulant status in genetically associated diseases such as sticky platelet syndrome, sickle cell disease and Glanzmann syndrome. We planned to review various published studies with the aim to find whether the coagulant profiles in these conditions alter the thrombotic manifestations and prognosis if these patients contract Covid-19. Various research studies revealed that patients with sticky platelet syndrome develop arterial and venous thrombosis, while those with sickle cell disease are known to develop complications such as deep vein thrombosis and pulmonary embolism. Moreover, patients with Glanzmann syndrome who usually have a bleeding tendency also rarely present with severe venous and arterial thrombosis and pulmonary embolism. Patients with sticky platelet syndrome and sickle cell disease and,, occasionally those with Glanzmann syndrome have a higher risk for thrombosis if infected with Covid-19. More studies are needed to better understand the clinical manifestations and designing standard management protocol for patients with sticky platelet syndrome, sickle cell disease and Glanzmann syndrome who contract Covid-19 infections.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Causes of thrombosis in Covid-19, sticky platelet syndrome, sickle cell disease and Glanzmann syndrome
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, comorbidities, and outcome among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–2059. - PMC - PubMed
    1. . WHO Dashboard. https://covid19.who.int/. 25th April 2021. 2021.
    1. Kubisz P, Stasko J, Holly P. Sticky platelet syndrome. Semin Thromb Hemost. 2013;6:674–683. - PubMed
    1. B. Aygun, I. Odame. A global perspective on sickle cell disease. Pediatric Blood & Cancer. 2012;2:386–390. - PubMed
    1. Toogeh G, Sharifian R, Lak M, et al. Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran. Am J Hematol. 2004;2:198–199. - PubMed

Publication types

LinkOut - more resources